RESEARCHERS
Grupo de Investigación en Psiquiatría y Enfermedades Neurodegenerativas.
> Orcid
Full Professor of Cell Biology in the Neurobiology Unit of the Institute of Biotechnology and Biomedicine of the Universitat de València (www.uv.es/biotecmed/ neuro), PI G23 CIBERSAM, PI Research Unit on Psychiatric and Neurodegenerative diseases INCLIVA. PhD in Neurobiology Universitat de València, postdoctoral work at the Laboratory of Neuroendocrinology of the Rockefeller University (New York). Research lines on the plasticity of the adult central nervous system and its involvement in the etiology and treatment of psychiatric disorders. Particularly interested in the alterations of inhibitory circuits and the influence of early adverse experiences. >160 papers in international JCR journals, h index: 50. Vicepresident and secretary Sociedad Española de Neurociencia (SENC) (2013-17). Director of the Graduate Program in Neurosciences, University of València (2005-10). Director of the Master in Basic and Applied Neurosciences, University of València (2012-14). PI 7 R+D projects from Spanish government and several projects from local government and private foundations. Local PI partner ERA-NET Neuron project. 11 thesis directed, all of the students working now in research/academia. Organizer of different events for the public dissemination of neuroscience: Pint of science, Brainshake, Neuromascletá, brain awareness week, @neuronacher on twitter, author ‘Neuroregeneración’ book (RBA/National Geographic). Traslation: A molecule away from madness ‘Sara M. Peskin’ (Publicacions UV).
> Orcid
Profesor Titular de la Facultad de Medicina de Valencia y Facultativo Especialista de Departamento en el Hospital Clínico Universitario de Valencia. Pertenece al INCLIVA y es Co- IP clínico del Grupo 23 del CIBERSAM. Sus méritos investigadores más relevantes incluyen:
- Reconocimiento de dos tramos de investigación: 1992-1998, 2006-2011
- Veintitres proyectos subvencionados en convocatorias competitivas, en 6 de ellos como investigador principal.
- Veinticuatro capítulos de libro y 1 libro completo.
- Ochenta y tres artículos en revistas de impacto (Web of Science). Indice h = 20
- Experto del Comité de enfermedades Neurológicas y Mentales del ISCIII en el periodo 04/2018 – 07/2019
- Experto de la Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS). Fecha 08/11/2017
- Miembro del Comité Ético de Investigación Clínica (CEIC) del Hospital de Sagunto. Durante el periodo 29/11/2009 – 01/01/2012
Miembro de la Comisión de Investigación del Hospital de Sagunto. Durante el periodo 01/03/2009 – 01/01/2012 - 10 Tesis Doctorales dirigidas.
- 20 Trabajos Fin de Grado dirigidos.
- Académico Correspondiente de la RAMCV.
Premios recibidos destacados:
- Premio de la Real Academia de Medicina 2015, lo que faculta para ingresar como Académico Correspondiente. Otorgado por la Real Academia de Medicina de la Comunitat Valenciana.
- Reconocimiento a la trayectoria profesional en el campo de la investigación científica de la Biomedicina y de las Ciencias de la Salud. Otorgado por la Generalitat Valenciana el 8/09/2010
- Premio al Joven Investigador Acreditado del Programa de Excelencia Investigadora de la Sociedad Española de Psiquiatría Biológica. Otorgado por la Sociedad Española de Psiquiatría Biológica (SEPB) el 23/10/2009
- Premio al mejor póster del Congreso. VII Congreso Nacional de Psiquiatría. Palma de Mallorca. Otorgado el 25/10/2003
- Diploma a la millor comunicació oral. I Jornada d’investigació en atenció primària de la Comunitat Valenciana. El impacto de la fibromiálgia en el núcleo familiar en un departamento de la Comunitat Valenciana. Luz de Myotanh Vázquez, Inmaculada Pereiró, Eduardo Aguilar. Fecha de concesión: 25/11/2021
> Orcid
Computer engineer specialized in quantification and post-processing of medical images. His work is mainly focused on the development of new imaging and post-processing techniques applied to neurological and psychiatric diseases. He completed his PhD in 2011 with a thesis focused on the improvement of morphometric methods in neuroimaging studies. His recent work is mainly related to new methods of imaging biomarkers and medical image processing, as well as their clinical application to the diagnosis and therapeutic monitoring of diseases. He is author of over 60 scientific papers, more than 100 communications to national and international conferences, 10 book chapters and 3 patents.
> Orcid
Full Professor of Human Genetics in the Genetics Department, Faculty of Biological Sciences, Universitat de València (www.uv.es/genetica). PI Human Genetics and Diseases models (GIUV2017-353), Member G23 CIBERSAM, Senior Investigator in the Research Unit on Psychiatric and Neurodegenerative diseases and Member Cross-Cutting Rare Diseases Program at INCLIVA. PhD in Biological Sciences, Universitat de València. Postdoctoral research at Baylor College of Medicine, Houston (EEUU) involved cloning the gene mutated in Friedreich ataxia disease. Research lines on identification of modifying genes, new targets, and molecules with therapeutic potential for Friedreich’s ataxia; identification of genetic risk factors and biomarkers of medication response in schizophrenia. >75 papers in international JCR journals, h index: 29. PI 6 I+D projects from Spanish government and several projects from local government and private foundations. Supervised 9 doctoral theses (each student is currently active in research/academia), and several research works. Coordinator of the Undergraduate Studies in Human Genetics at the Faculty of Biological Sciences, Universitat de Valéncia (since 2010). Accredited by the Spanish Association of Human Genetics (AEGH) for contributions to human genetics. Regularly involved in communicating research findings to patient associations, FEDAES and ASVAH.
> Orcid
Dr. Olga Rivero’s research career focuses on improving our understanding of how risk genes for neuropsychiatric and neurodevelopmental disorders impact on brain function and ultimately on behavior. She is biologist and developed her undergraduate and PhD research career at the Department of Genetics, University of Valencia, with focus on the genetics of schizophrenia. As a postdoctoral researcher, she moved to the Division of Molecular Psychiatry, University of Würzburg, to study the neurobiology of attention deficit / hyperactivity disorder. In Würzburg, she experienced a strong shift to new methodologies and approaches which have enriched her research career to a great extent, ranging from cellular imaging and functional studies, to phenotyping of genetically modified mice at the molecular, cellular and systems levels, always with a translational perspective.
Back to the Spanish academia, Dr. Rivero obtained in 2021 a Miguel Servet Contract to work as Emergent Researcher at the INCLIVA Research Group on Psychiatry and Neurodegenerative Disorders. In this new stage, she will focus in the generation of neuronal cell lines from healthy subjects and first episode of psychosis (FEP) patients, in order to identify biomarkers of psychosis and poor medication response. This project will be supported by Carlos III Health Institute.
In addition, during her whole research career, Dr. Rivero has participated in the publication of 31 manuscripts, (25 of them in the first Quartile, 10 of them as main author) as well as in the supervision of 3 PhD, 1 MD, 7 bachelor and 8 master theses.